| 000 | 01428 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515193438.0 | ||
| 264 | 0 | _c20100107 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1464-5246 | ||
| 024 | 7 |
_a10.3109/02652040802666910 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGayakwad, Sanjay G | |
| 245 | 0 | 0 |
_aFormulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. _h[electronic resource] |
| 260 |
_bJournal of microencapsulation _cDec 2009 |
||
| 300 |
_a692-700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
| 650 | 0 | 4 | _aDiffusion |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aSerum Albumin |
| 700 | 1 | _aBejugam, Naveen K | |
| 700 | 1 | _aAkhavein, Nima | |
| 700 | 1 | _aUddin, Nasir A | |
| 700 | 1 | _aOettinger, Carl E | |
| 700 | 1 | _aD'Souza, Martin J | |
| 773 | 0 |
_tJournal of microencapsulation _gvol. 26 _gno. 8 _gp. 692-700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/02652040802666910 _zAvailable from publisher's website |
| 999 |
_c19277037 _d19277037 |
||